To further verify the contribution of CD147 in mediating the effect of HG and CML on MMP expression and activity, we utilized a specific set of CD147-targeting siRNAs that was validated as an effective tool for downregulating CD147 mRNA (Figure 7A). This evidence concerns the gene BSG and chronic myelogenous leukemia, BCR-ABL1 positive.